Max Estates Adjusts Evaluation Score Amid Mixed Performance Indicators and Growth Challenges
Max Estates, a midcap realty firm, has recently adjusted its evaluation score, reflecting a shift in market sentiment. The company reported a 47.32% increase in net sales to Rs 79.82 crore and a 215% rise in profit after tax to Rs 17.34 crore, despite facing long-term growth challenges.
Max Estates, a midcap player in the realty sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical landscape, moving from a sideways trend to a mildly bullish outlook. The company's recent performance indicators show a mixed picture. Over the last quarter, Max Estates reported a significant growth in net sales, reaching Rs 79.82 crore, which represents a 47.32% increase. Additionally, the profit after tax for the latest quarter surged to Rs 17.34 crore, marking a remarkable growth of 215% compared to the previous four-quarter average.
Despite these positive developments, the company faces challenges with long-term growth, as its operating profit has declined at an annual rate of 19.82% over the past five years. The return on equity stands at 1.8, indicating a relatively expensive valuation with a price-to-book ratio of 3.5, which is above the average historical valuations of its peers.
Max Estates also boasts a high institutional holding of 33.73%, suggesting that these investors have the resources to analyze the company's fundamentals effectively.
For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
